Drug-eluting beads show benefit in liver cancer
This article was originally published in Clinica
Executive Summary
A study of drug-eluting beads has suggested that the technology has potential in the treatment of hepatocellular carcinoma (HCC). The beads improved some patients' cancer to the degree that they were given liver transplants, having previously been considered too ill for the procedure.